Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
The decision to come work here earlier this year has been a very positive one
O que você mais gosta nos lideres?
Too new an emplpyee to comment
Qual é a melhor parte das suas compensações?
Strong Medical coverage, vacation policy, company 401k match
O que faz você mais feliz no trabalho?
Engaging colleagues, to meet their needs
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
The company's commitment to patients
Other Employee Reviews for Karyopharm Therapeutics
×